{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:51:18Z","timestamp":1792363878945,"version":"4.4.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T00:00:00Z","timestamp":1364256000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0059820","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T20:48:51Z","timestamp":1364330931000},"page":"e59820","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Characterization of a Single-Chain Variable Fragment Recognizing a Linear Epitope of A\u03b2: A Biotechnical Tool for Studies on Alzheimer\u2019s Disease?"],"prefix":"10.1371","volume":"8","author":[{"given":"Silke","family":"Dornieden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"M\u00fcller-Schiffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Sticht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeliz","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"W\u00f6rdehoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Korth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne Aileen","family":"Funke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Willbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer&apos;s disease","volume":"3","author":"R Brookmeyer","year":"2007","journal-title":"Alzheimers & Dementia"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2896","article-title":"Alzheimer&apos;s disease: strategies for disease modification","volume":"9","author":"M Citron","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0092-8674(93)90312-E","article-title":"Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide","volume":"75","author":"C Haass","year":"1993","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","article-title":"The precursor of Alzheimer&apos;s disease amyloid A4 protein resembles a cell-surface receptor","volume":"325","author":"J Kang","year":"1987","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0092-8674(89)90177-3","article-title":"Identification, biogenesis, and localization of precursors of Alzheimer&apos;s disease A4 amyloid protein","volume":"57","author":"A Weidemann","year":"1989","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Puzzo D, Arancio O (2012) Amyloid-beta Peptide: Dr. Jekyll or Mr. Hyde? J Alzheimers Dis.","DOI":"10.3233\/JAD-2012-129033"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer&apos;s disease: the amyloid cascade hypothesis","volume":"256","author":"JA Hardy","year":"1992","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer&apos;s disease","volume":"6","author":"DJ Selkoe","year":"1991","journal-title":"Neuron"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000100355","article-title":"Amyloid-beta aggregation","volume":"4","author":"VH Finder","year":"2007","journal-title":"Neurodegener Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer&apos;s amyloid beta-peptide","volume":"8","author":"C Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1\u201342 are potent central nervous system neurotoxins","volume":"95","author":"MP Lambert","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway","volume":"27","author":"GM Shankar","year":"2007","journal-title":"J Neurosci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A beta oligomers - a decade of discovery","volume":"101","author":"DM Walsh","year":"2007","journal-title":"J Neurochem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease","volume":"6","author":"F Bard","year":"2000","journal-title":"Nat Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer&apos;s disease","volume":"98","author":"RB DeMattos","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1074\/jbc.M511018200","article-title":"Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice","volume":"281","author":"EB Lee","year":"2006","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1523\/JNEUROSCI.1090-04.2004","article-title":"Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition","volume":"24","author":"DM Wilcock","year":"2004","journal-title":"J Neurosci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3233\/JAD-2011-110986","article-title":"Strategies, development, and pitfalls of therapeutic options for Alzheimer&apos;s disease","volume":"28","author":"C Haas","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/489013a","article-title":"Alzheimer&apos;s drugs take a new tack","volume":"489","author":"E Callaway","year":"2012","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/WCO.0b013e3281a47744","article-title":"Amyloid imaging in Alzheimer&apos;s disease","volume":"20","author":"A Nordberg","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.neuropsychologia.2008.03.020","article-title":"Amyloid imaging in Alzheimer&apos;s disease","volume":"46","author":"A Nordberg","year":"2008","journal-title":"Neuropsychologia"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0506938103","article-title":"Screening phage display libraries for organ-specific vascular immunotargeting in vivo","volume":"103","author":"P Valadon","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1471-4159.2007.05064.x","article-title":"Antibody-based approaches in Alzheimer&apos;s research: safety, pharmacokinetics, metabolism, and analytical tools","volume":"104","author":"P Lichtlen","year":"2008","journal-title":"J Neurochem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","article-title":"Engineered antibody fragments and the rise of single domains","volume":"23","author":"P Holliger","year":"2005","journal-title":"Nat Biotechnol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3233\/JAD-2010-100195","article-title":"Modified immunotherapies against Alzheimer&apos;s disease: toward safer and effective amyloid clearance","volume":"21","author":"YJ Wang","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1021\/bi049933o","article-title":"Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity","volume":"43","author":"R Liu","year":"2004","journal-title":"Biochemistry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/protein\/gzn052","article-title":"Engineered antibody intervention strategies for Alzheimer&apos;s disease and related dementias by targeting amyloid and toxic oligomers","volume":"22","author":"R Robert","year":"2009","journal-title":"Protein Eng Des Sel"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.molimm.2007.08.008","article-title":"Epitope mapping and neuroprotective properties of a human single chain FV antibody that binds an internal epitope of amyloid-beta 1\u201342","volume":"45","author":"RS Solorzano-Vargas","year":"2008","journal-title":"Mol Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00001756-200302100-00022","article-title":"Screening and characterization of human single-chain Fv antibody against beta-amyloid peptide 40","volume":"14","author":"J Cai","year":"2003","journal-title":"Neuroreport"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.bbi.2010.05.010","article-title":"Intramuscular delivery of a single chain antibody gene prevents brain Abeta deposition and cognitive impairment in a mouse model of Alzheimer&apos;s disease","volume":"24","author":"YJ Wang","year":"2010","journal-title":"Brain, behavior, and immunity"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e18296","DOI":"10.1371\/journal.pone.0018296","article-title":"Chronic intranasal treatment with an anti-Abeta(30\u201342) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer&apos;s disease","volume":"6","author":"S Cattepoel","year":"2011","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-60327-058-8_8","article-title":"Protein structure modeling with MODELLER","volume":"426","author":"N Eswar","year":"2008","journal-title":"Methods Mol Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"15659","DOI":"10.1073\/pnas.0705888104","article-title":"Molecular basis for passive immunotherapy of Alzheimer&apos;s disease","volume":"104","author":"AS Gardberg","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/381272a0","article-title":"Errors in protein structures","volume":"381","author":"RW Hooft","year":"1996","journal-title":"Nature"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"AC Wallace","year":"1995","journal-title":"Protein Eng"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"8743","DOI":"10.1002\/anie.201004437","article-title":"Combining Independent Drug Classes into Superior, Synergistically Acting Hybrid Molecules","volume":"49","author":"A Muller-Schiffmann","year":"2010","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/356577a0","article-title":"Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein","volume":"356","author":"H Bueler","year":"1992","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1073\/pnas.85.16.5879","article-title":"Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli","volume":"A85","author":"JS Huston","year":"1988","journal-title":"Proc Natl Acad Sci U S"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1021\/bi800253c","article-title":"Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein","volume":"47","author":"SR Leliveld","year":"2008","journal-title":"Biochemistry"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"8198","DOI":"10.1073\/pnas.0813399106","article-title":"An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies","volume":"106","author":"D Schonfeld","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1111\/j.1742-4658.2006.05263.x","article-title":"Physiochemical characterization of the Alzheimer&apos;s disease-related peptides A beta 1\u201342Arctic and A beta 1\u201342wt","volume":"273","author":"AS Johansson","year":"2006","journal-title":"FEBS J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"22908","DOI":"10.1074\/jbc.271.37.22908","article-title":"Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay","volume":"271","author":"N Ida","year":"1996","journal-title":"J Biol Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00253-007-1133-3","article-title":"Improved expression of a soluble single chain antibody fusion protein containing tumor necrosis factor in Escherichia coli","volume":"77","author":"S Kim","year":"2007","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.molimm.2008.07.023","article-title":"Complementarity determining regions of an anti-prion protein scFv fragment orchestrate conformation specificity and antiprion activity","volume":"46","author":"A Muller-Schiffmann","year":"2009","journal-title":"Mol Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/0959-440X(92)90234-X","article-title":"Primary structure of immunoglobulins through evolution","volume":"2","author":"SL Hsu E","year":"1992","journal-title":"Curr Opin Struct Biol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/pro.5560020312","article-title":"Thioflavine T interaction with synthetic Alzheimer&apos;s disease beta-amyloid peptides: detection of amyloid aggregation in solution","volume":"2","year":"1993","journal-title":"Protein Scity"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033583506004173","article-title":"Molecular structure of amyloid fibrils: insights from solid-state NMR","volume":"39","author":"R Tycko","year":"2006","journal-title":"Q Rev Biophys"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.intimp.2009.10.005","article-title":"Antibody concentrations to Abeta1\u201342 monomer and soluble oligomers in untreated and antibody-antigen-dissociated intravenous immunoglobulin preparations","volume":"10","author":"AC Klaver","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jneumeth.2010.01.018","article-title":"Measurement of anti-Abeta1\u201342 antibodies in intravenous immunoglobulin with indirect ELISA: the problem of nonspecific binding","volume":"187","author":"AC Klaver","year":"2010","journal-title":"J Neurosci Methods"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.bbrc.2007.07.107","article-title":"Reduced serum level of antibodies against amyloid beta peptide is associated with aging in Tg2576 mice","volume":"361","author":"JH Sohn","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"9564","DOI":"10.1074\/jbc.270.16.9564","article-title":"Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture","volume":"270","author":"MB Podlisny","year":"1995","journal-title":"J Biol Chem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1021\/bi9001216","article-title":"Structures of Abeta-related peptide\u2013monoclonal antibody complexes","volume":"48","author":"A Gardberg","year":"2009","journal-title":"Biochemistry"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-3940(96)12970-0","article-title":"Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain","volume":"215","author":"TC Saido","year":"1996","journal-title":"Neurosci Lett"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.1021\/bi900818a","article-title":"Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides","volume":"48","author":"D Schlenzig","year":"2009","journal-title":"Biochemistry"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033583506004173","article-title":"Molecular structure of amyloid fibrils: insights from solid-state NMR","volume":"39","author":"R Tycko","year":"2006","journal-title":"Quarterly reviews of biophysics"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"UK Laemmli","year":"1970","journal-title":"Nature"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0059820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T12:32:55Z","timestamp":1644669175000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0059820"}},"subtitle":[],"editor":[{"given":"Riqiang","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,26]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0059820","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,26]]}}}